| Peggy L Harris, APRN | |
|
444 S Main St, Madisonville, KY 42431-2846 | |
| (270) 821-4444 | |
| (270) 821-9188 |
| Full Name | Peggy L Harris |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 444 S Main St, Madisonville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992173330 | NPI | - | NPPES |
| 7100368720 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 1069555 (Kentucky) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 3009842 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Home Care | Madisonville, KY | Home health agency |
| Caretenders | Owensboro, KY | Home health agency |
| Owensboro Health Regional Hospital | Owensboro, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Owensboro Health Medical Group Inc | 0648255034 | 358 |
News Archive
In the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a senior fellow at CGD, introduces the center's new online forum in which they "have asked prominent thinkers and practitioners what reforms the Global Fund should prioritize and how it should best fulfill its mandate of improving the way development aid is managed in addition to advancing the fight against the three diseases as its Board considers new policies and its new Executive Director prepares to takes office."
Convalescent plasma therapy for COVID-19 patients - an experimental approach of giving a transfusion of plasma collected from a donor who has recovered from COVID-19 to a patient with an active infection - is the focus of a new two-part research initiative at Penn Medicine.
Researchers at Oregon State University have found one gene in the human body that appears to be a master regulator for skin development, in research that could help address everything from skin diseases such as eczema or psoriasis to the wrinkling of skin as people age.
Type 1 diabetes is the autoimmune form of diabetes, in which the patients' insulin-producing beta cells are destroyed by their own immune system. "We know that if a person has two autoantibodies and one of them is against insulin, there is a 50 per cent risk that they will develop type 1 diabetes within five years. It doesn't matter how old you are", says Ake Lernmark, Professor of Experimental Diabetes Research at Lund University in Sweden.
› Verified 9 days ago
| Entity Name | Owensboro Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235518242 PECOS PAC ID: 0648255034 Enrollment ID: O20040621000818 |
News Archive
In the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a senior fellow at CGD, introduces the center's new online forum in which they "have asked prominent thinkers and practitioners what reforms the Global Fund should prioritize and how it should best fulfill its mandate of improving the way development aid is managed in addition to advancing the fight against the three diseases as its Board considers new policies and its new Executive Director prepares to takes office."
Convalescent plasma therapy for COVID-19 patients - an experimental approach of giving a transfusion of plasma collected from a donor who has recovered from COVID-19 to a patient with an active infection - is the focus of a new two-part research initiative at Penn Medicine.
Researchers at Oregon State University have found one gene in the human body that appears to be a master regulator for skin development, in research that could help address everything from skin diseases such as eczema or psoriasis to the wrinkling of skin as people age.
Type 1 diabetes is the autoimmune form of diabetes, in which the patients' insulin-producing beta cells are destroyed by their own immune system. "We know that if a person has two autoantibodies and one of them is against insulin, there is a 50 per cent risk that they will develop type 1 diabetes within five years. It doesn't matter how old you are", says Ake Lernmark, Professor of Experimental Diabetes Research at Lund University in Sweden.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peggy L Harris, APRN Po Box 1595, Owensboro, KY 42302-1595 Ph: (270) 691-8070 | Peggy L Harris, APRN 444 S Main St, Madisonville, KY 42431-2846 Ph: (270) 821-4444 |
News Archive
In the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, director of global health policy and a senior fellow at CGD, introduces the center's new online forum in which they "have asked prominent thinkers and practitioners what reforms the Global Fund should prioritize and how it should best fulfill its mandate of improving the way development aid is managed in addition to advancing the fight against the three diseases as its Board considers new policies and its new Executive Director prepares to takes office."
Convalescent plasma therapy for COVID-19 patients - an experimental approach of giving a transfusion of plasma collected from a donor who has recovered from COVID-19 to a patient with an active infection - is the focus of a new two-part research initiative at Penn Medicine.
Researchers at Oregon State University have found one gene in the human body that appears to be a master regulator for skin development, in research that could help address everything from skin diseases such as eczema or psoriasis to the wrinkling of skin as people age.
Type 1 diabetes is the autoimmune form of diabetes, in which the patients' insulin-producing beta cells are destroyed by their own immune system. "We know that if a person has two autoantibodies and one of them is against insulin, there is a 50 per cent risk that they will develop type 1 diabetes within five years. It doesn't matter how old you are", says Ake Lernmark, Professor of Experimental Diabetes Research at Lund University in Sweden.
› Verified 9 days ago
Holly Marie Griffin, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 243 East Ayer Parkway, Madisonville, KY 42431 Phone: 270-584-9050 | |
Amber Lynn O'hearn, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1815 Castleton Dr, Madisonville, KY 42431 Phone: 270-871-8016 | |
Michael W. Rager, APRN, DNP, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 Clinic Dr, Madisonville, KY 42431 Phone: 270-825-7200 | |
Sarah Ruth Peyton, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1851 N Main St, Madisonville, KY 42431 Phone: 270-825-7268 Fax: 270-825-6615 | |
Ashleigh Dena Hickerson, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 Hospital Dr, Madisonville, KY 42431 Phone: 270-875-3502 Fax: 270-825-5551 | |
Ms. Rosa Lee Langley, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3895 Brown Rd, Madisonville, KY 42431 Phone: 859-539-7014 | |
Amy Nicole Mercer, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1851 N Main St, Madisonville, KY 42431 Phone: 270-825-7268 Fax: 270-825-6615 |